Patents by Inventor Anita Driessen-Mol

Anita Driessen-Mol has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11684697
    Abstract: The present invention concerns a tissue-engineered medical device, as well as a method for the production said medical device, comprising the following steps: providing a polymer scaffold comprising a mesh comprising polyglycolic acid, and a coating comprising poly-4-hydroxybutyrate; application of a cell suspension containing preferably human cells to the polymer scaffold; placement of the seeded polymer scaffold in a bioreactor and mechanical stimulation by exposure to a pulsatile flux of incremental intensity, thereby forming an extracellular matrix; mounting of the graft on a conduit stabilizer and incubation in cell culture medium; decellularisation of the graft in a washing solution; nuclease treatment of the graft; and rinsing of graft. The invention further comprises and various steps of quality control of the tissue-engineered medical device.
    Type: Grant
    Filed: August 28, 2018
    Date of Patent: June 27, 2023
    Assignee: UNIVERSITÄT ZÜRICH
    Inventors: Simon-Philipp Hoerstrup, Maximilian Y. Emmert, Frank Baaijens, Anita Driessen-Mol
  • Publication number: 20210060208
    Abstract: The present invention concerns a tissue-engineered medical device, as well as a method for the production said medical device, comprising the following steps: providing a polymer scaffold comprising a mesh comprising polyglycolic acid, and a coating comprising poly-4-hydroxybutyrate; application of a cell suspension containing preferably human cells to the polymer scaffold; placement of the seeded polymer scaffold in a bioreactor and mechanical stimulation by exposure to a pulsatile flux of incremental intensity, thereby forming an extracellular matrix; mounting of the graft on a conduit stabilizer and incubation in cell culture medium; decellularisation of the graft in a washing solution; nuclease treatment of the graft; and rinsing of graft. The invention further comprises and various steps of quality control of the tissue-engineered medical device.
    Type: Application
    Filed: August 28, 2018
    Publication date: March 4, 2021
    Applicant: UNIVERSITÄT ZÜRICH
    Inventors: Simon-Philipp HOERSTRUP, Maximilian Y. EMMERT, Frank BAAIJENS, Anita DRIESSEN-MOL
  • Patent number: 10213297
    Abstract: Various inserts, called shapers and spacers, are provided for controlling tissue engineered heart valve (TEHV) leaflet geometry during culture. These inserts will prevent TEHV leaflet retraction during culture, be able to control the leaflet geometry during culture, enable culturing TEHV leaflets with a larger coaptation area, control the height of the coaptation area, maintain TEHV leaflet curvatures, and/or enable possibilities to culture TEHV leaflets in open configuration.
    Type: Grant
    Filed: September 24, 2014
    Date of Patent: February 26, 2019
    Assignees: UNIVERSITAET ZUERICH, TECHNISCHE UNIVERSITEIT EINDHOVEN
    Inventors: Bart Sanders, Sandra Vossen-Loerakker, Anita Driessen-Mol, Simon Philipp Hoerstrup, Franciscus Petrus Thomas Baaijens